Literature DB >> 26351328

Walking the Tightrope Between Treatment Efficacy and Price.

Peter B Bach1.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26351328     DOI: 10.1200/JCO.2015.63.7397

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Dynamic Assessment of Value During High-Cost Cancer Treatment: A Response to American Society of Clinical Oncology and European Society of Medical Oncology.

Authors:  Charles W Given; Barbara A Given; Cathy J Bradley; John C Krauss; Alla Sikorskii; Eric Vachon
Journal:  J Oncol Pract       Date:  2016-10-31       Impact factor: 3.840

Review 2.  Next-generation multiple myeloma treatment: a pharmacoeconomic perspective.

Authors:  S Vincent Rajkumar; Jean Luc Harousseau
Journal:  Blood       Date:  2016-10-14       Impact factor: 22.113

3.  Cost-effectiveness of radiation and chemotherapy for high-risk low-grade glioma.

Authors:  Yushen Qian; Satoshi Maruyama; Haju Kim; Erqi L Pollom; Kiran A Kumar; Alexander L Chin; Jeremy P Harris; Daniel T Chang; Allison Pitt; Eran Bendavid; Douglas K Owens; Ben Y Durkee; Scott G Soltys
Journal:  Neuro Oncol       Date:  2017-11-29       Impact factor: 12.300

4.  Health Care Spending: Changes in the Perceptions of the Australian Public.

Authors:  Jane Robertson; David A Newby; Emily J Walkom
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.